Nutritional Oncology Analysis

Abstract

References

Pienta KJ Etiology, epidemiology, and prevention of carcinoma of the prostate . In: Walsh P , ed. Campbell's Urology. 7th ed. Philadelphia, Pa: Saunders; 1998 :2489-2496.

Hsing AW , Devesa SS Trends and patterns of prostate cancer: what do they suggest? Epidemiol Rev. 2001;23(1):3-13.

Scardino PT , Wheeler TM , Kattan MW Is cure of prostate cancer possible in those for whom it is necessary? In: Kurth K, Mickisch G, Schroder F, eds. Renal, Bladder, and Prostate Cancer: An Update. Proceedings of the PACIOU Meeting. Casterton Hall, England: Parthenon; 1999:131.

Litwin MS , Flanders SG , Pasta DJ , et al. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis for CaPSURE. Cancer of the Prostate Strategic Urological Research Endeavor. Urology . 1999;54:503.

Walsh PC Anatomic radical prostatectomy: evolution of the surgical technique . J Urol. 1998;160(part 2):2418-2424.

Scher HI , Isaacs JT , Zelefsky MJ , Scardino PT Prostate cancer. In: Abeloff M , Armitage J , Lichter A , Neiderhuber J , eds. Clinical Oncology. 2nd ed. New York, NY: Churchill Livingstone; 2000:1823-1884.

Dillioglugil O. , Leibman BD , Leibman NS , et al. Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol. 1997;157:1760-1767.

Soloway MS , Sharifi R. , Wajsman Z. , et al. Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxMo) prostate cancer. The Lupron Depot Neoadjuvant Prostate Cancer Study Group. J Urol. 1995;154: 424-428.

Benson RC, Jr , Gill GM Estramustine phosphate compared with diethylstilbestrol. A randomized, double-blind, crossover trial for stage D prostate cancer. Am J Clin Oncol. 1986;9:341-351.

10.

Moore MJ , Osoba D. , Murphy D. , et al. Use of palliative endpoints to evaluate the effect of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer . J Clin Oncol. 1994;12:689-694.

11.

Pound CR , Partin AW , Eisenberger MA , Chan DW , Pearson JD , Walsh PC Natural history of progression after PSA elevation following radical prostatectomy . JAMA. 1999;281:1591-1597.

12.

Albertsen PC , Hanley JA , Gleason DF , et al. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA. 280; 1998:975-980.

13.

Saxe GA , Hebert JR , Carmody JF , et al. Can diet in conjunction with stress reduction affect the rate of increase in prostate specific antigen after biochemical recurrence of prostate cancer? J Urol. 2001;166(12):2202-2207.

14.

Heber D. , Fair WR , Ornish D. Nutrition and prostate cancer. 2nd ed. Santa Monica, Calif: CaPCure Nutrition Project; 1998.

15.

Parkin DM , Muir CS Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ. 1992;120:45-173.

16.

Chen C. Risk of prostate cancer in relation to polymorphisms of metabolic genes. Epidemiol Rev. 2001;23(1):30-35.

17.

Shimuzu H. , Ross RK , Bernstein L. , Yatani R. , Henderson BE , Mack TM Cancers of the prostate and breast among Japanese and white immigrants to Los Angeles County. Br J Cancer. 1991;63:963-966.

18.

Muir CS , Nectoux J. , Staszewski J. The epidemiology of prostatic cancer: geographical distributions and time-trends . Acta Oncol. 1991;30:133-140.

19.

Fair WR , Fleshner NE , Heston WD Cancer of the prostate: a nutritional disease? Urology . 1997;50:840-848.

20.

Pienta K. , Esper P. Risk factors for prostate cancer. Ann Intern Med. 1993;118:793-803.

21.

Hickey K. , Do K-A. , Green A. Smoking and prostate cancer. Epidemiol Rev. 2001;23(1):115-125.

22.

Lee I.-M. , Sesso HD , Chen J. -J, Paffenberger RS Does physical activity play a role in the prevention of prostate cancer? Epidemiol Rev. 2001;23(1):132-137.

23.

Strickler HD , Goedert JJ Sexual behavior and evidence for an infectious cause of prostate cancer. Epidemiol Rev. 2001 ;23(1):144-151.

24.

Mandel JS , Schuman LM Sexual factors and prostatic cancer. J Gerontol. 1987;42:259-264.

25.

Oishi K. , Okada K. , Yoshida O. , et al. A case-control study of prostatic cancer in Kyoto, Japan: sexual risk factors. Prostate. 1990;17:269-279.

26.

Herbert JT , Birkhoff JD , Feorino PM , et al. Herpes simplex type 2 and cancer of the prostate. J Urol. 1976;116:611-612.

27.

Baker LH , Mebust WK , Chin TD , et al. The relationship of herpesvirus to carcinoma of the prostate . J Urol. 1981; 125:370-374.

28.

Giovannucci E. Medical history and etiology of prostate cancer . Epidemiol Rev. 2001;23(1):159-162.

29.

Parent M-E. , Siemiatycki J. Occupation and prostate cancer . Epidemiol Rev. 2001;23(1):138-143.

30.

Gatenbach L. , Aronsson A. , Johansson B. , Stromberg L. Stress stimuli-induced histopathological changes in the prostate: an experimental study in the rat . Prostate . 1987;11:69-76.

31.

Cruess DG , Antoni MH , McGregor BA , et al. Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer. Psychosom Med. 2000;62:304-308.

32.

Sephton SE , Sapolsky RM , Kraemer HC , Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92:994-1000.

33.

Miller HC Stress prostatitis. Urology. 1988;32:507-510.

34.

Kolonel L. Fat, meat, and prostate cancer. Epidemiol Rev. 2001;23(1):72-81.

35.

Chan JM , Giovannucci EL Dairy products, calcium, and vitamin D and risk of prostate cancer . Epidemiol Rev. 2001; 23(1):87-92.

36.

Giovannucci E. , Rimm EB , Wolk A. , et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res. 1998 ;58:442-447.

37.

Mukherjee P. , Sotnikov AV , Mangian HJ , et al. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J Natl Cancer Inst. 1999;91: 512-523.

38.

Satia-Abouta J. , Patterson RE , Schiller RN , Kristal AR Energy from fat is associated with obesity in U.S. men: results from the Prostate Cancer Prevention Trial. Prev Med. 2002;34(5): 493-501.

39.

Nomura AMY. Body size and prostate cancer. Epidemiol Rev. 2001;23(1):126-131.

40.

Cohen P. , Peehl DM , Rosenfeld RG The IGF axis in the prostate. Horm Metab Res. 1994;26:81-84.

41.

Ghosh J. , Myers CE Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun. 1997;233:418-423.

42.

Myers CE Differentiating agents and nontoxic therapies. Urol Clinics North Amer. 1999;26(2):341-351.

43.

Ghosh J. , Myers CE Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci. 1998;95(22):13182-13187.

44.

Chan J. , Giovannucci EL Vegetables, fruits, associated micro-nutrients, and risk of prostate cancer . Epidemiol Rev. 2001; 23(1):82-86.

45.

Cohen JH , Kristal AR , Stanford JL Fruit and vegetable intake and prostate cancer risk. J Natl Cancer Inst. 2000;92:61-68.

46.

Brooks JD , Paton VG , Vidanes G. Potent induction of phase 2 enzymes in human prostate cancer cells by sulforaphane . Cancer Epidemiol Biomarkers Prev. 2001;10(9):949-954.

47.

Chinni SR , Li Y. , Upadhyay S. , Koppolu PK , Sarkar FH Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene. 2001;20:2927-2936.

48.

Brody T. Vitamin A. In: Brody T , ed. Nutritional Biochemistry. Boston, Mass: Academic Press; 1999:554-565.

49.

World Cancer Research Fund and American Institute for Cancer Research. Food, Nutrition, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research; 1997.

50.

Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiological literature. J Natl Cancer Inst. 1999;91:317-331.

51.

Heinonen OP , Albanes D. , Virtamo J. , et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998;90:440-446.

52.

Gann PH , Ma J. , Giovannucci E. , et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 1999;59:1225-1230.

53.

Eichholzer M. , Stahelin HB , Gey KF , et al. Predictions of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel Study. Int J Cancer. 1996; 66:145-150.

54.

Chan JM , Stampfer MJ , Ma J. , et al. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev. 1999;8:893-899.

55.

Platz EA , Helzlsouer KJ Selenium, zinc, and prostate cancer. Epidemiol Rev . 2001;23(1):93-101.

56.

Redman C. , Scott JA , Baines AT , et al. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett. 1998;125:103-110.

57.

Menter DG , Sabichi AL , Lippman SM Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev. 2000;9:1171-1182.

58.

Brawley OW , Parnes H. Prostate cancer prevention trials in the USA. Eur J Cancer . 2000;36:1312-1315.

59.

Barnes S. Role of phytochemicals in prevention and treatment of prostate cancer . Epidemiol Rev. 2001;23(1):102-105.

60.

Schleicher RL , Lamartiniere CA , Zheng M. , et al. The inhibitory effect of genisteine on the growth and metastasis of a transplantable rat accessory sex gland carcinoma . Cancer Lett. 1999;136:195-201.

61.

Onozawa M. , Kawamori T. , Baba M. , et al. Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 rats. Jpn J Cancer Res . 1999;90:393-398.

62.

Gupta S. , Mukhtar H. Green tea and prostate cancer. Urol Clin North Amer . 2002;29(1):49-57.

63.

Chhabra SK , Yang CS Tea and prostate cancer. Epidemiol Rev. 2001 ;23(1):106-109.

64.

Liao S. , Hiipakka RA Selective inhibition of steroid 5 alphareductase isoenzymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem Biophys Res Commun . 1995;214:833-838.

65.

Michaud DS , Augustsson K. , Rimm EB , Stampfer MJ , Willett WC , Giovannucci E. A prospective study on intake of animal products and risk of prostate cancer . Cancer Causes Control. 2002;12(6):557-567.

66.

Chan JM , Stampfer MJ , Ma J. , et al. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev. 1999;8:893-899.

67.

Fleshner NE Vitamin E and prostate cancer. Urol Clin North Amer. 2002;29(1):107-113.

68.

Carter JP , Saxe GA , Newbold V. , Peres CE , Campeau RJ , Bernal-Green L. Hypothesis: dietary management may improve survival from nutritionally linked cancers based on analysis of representative cases. J Am Coll Nutr. 1993;12:209-226.

69.

Tymchuk CN , Barnard RJ , Heber D. , Aronson WJ Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. J Urol. 2001;166(3):1185-1189.

70.

Dorgan JF , Judd JT , Longcope C. , et al. Effects of dietary fat and fiber on plasma and urine estrogens in men: a controlled feeding study. Am J Clin Nutr. 1996;64:850-855.

71.

Tymchuk CN , Kessler SB , Aronson WJ , Barnar RJ Effects of diet and exercise on insulin resistance, sex hormone-binding globulin, and prostate-specific antigen. Nutr Cancer. 1998; 31:127-131.